A cancer charity is investing £5 million in research in the region.
Among grants announced today by Yorkshire Cancer Research, £1.5m will go towards a trial in Leeds.
It will examine whether long-term treatment with a natural anti-cancer compound called EPA, found in cold water fish, improves outcomes for patients with colorectal cancer undergoing surgery.
A second award, also of £1.5m, will invest in a five-year project aimed at improving the survival of bowel cancer patients. Researchers at Leeds University will test new methods of assessing a patient’s response to treatments, develop an improved understanding of which treatments to use before surgery and speed up the evaluation of those treatments through novel clinical trials.
Another 18-month study led by Leeds University will investigate access to palliative care services to find out why patients are not receiving the support they need in a consistent way across the county.
The charity’s chief executive officer, Charles Rowett, said: “This is a very substantial investment in projects with a huge regional significance which will take us one step closer to reducing the devastating impact of cancer on people who live in Yorkshire.
“Our £5m investment has proven without a doubt that there is a huge need for more research to address cancer inequalities in our region, especially as national charities and the government continue to reduce their research expenditure in the North of England.
“We were overwhelmed by the number and quality of the applications received and it is clear that more needs to be done to ensure that everyone in Yorkshire has fair access to the same quality of diagnosis, treatment and care as they would elsewhere in the county.”